30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Actuate Therapeutics Inc (ACTU)

Track

The most recent insider trading activity occurred on January 5, 2026, with a significant sell transaction by an executive. Prior to this, in December 2025, a proposed sale was noted. Earlier transactions in June 2025 showed insider buying, contrasting with several sell transactions in August 2024.
Stock chart
Ticker: ACTU Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
THOMSON TODD S
1 sale — total 1,624,000 USD
Sale 5 Jan 2026
Value US$4,542,047.19 | Price 265.44 | Shares 8,411
Proposed sale 11 Dec 2025
Value US$3,156,842.99 | Price 403.23 | Shares 81,000
Buy 27 Jun 2025
Value US$499,996.00 | Price 7.00 | Shares 71,428
Buy 27 Jun 2025
Value US$499,996.00 | Price 7.00 | Shares 71,428
Buy 27 Jun 2025
Value US$499,996.00 | Price 7.00 | Shares 71,428
Sale 14 Aug 2024
Value US$150,000.00 | Price 8.00 | Shares 18,750
Sale 14 Aug 2024
Value US$20,916.00 | Price 9.00 | Shares 2,324
Sale 14 Aug 2024
Value US$156,249.00 | Price 9.00 | Shares 17,361
Sale 14 Aug 2024
Value US$47,826.00 | Price 9.00 | Shares 5,314
Buy 14 Aug 2024
Value US$1,000,000.00 | Price 8.00 | Shares 125,000
Buy 14 Aug 2024
Value US$3,000,000.00 | Price 8.00 | Shares 375,000
Sale 14 Aug 2024
Value US$20,916.00 | Price 9.00 | Shares 2,324
Sale 14 Aug 2024
Value US$156,249.00 | Price 9.00 | Shares 17,361
Sale 14 Aug 2024
Value US$47,826.00 | Price 9.00 | Shares 5,314
Buy 14 Aug 2024
Value US$1,000,000.00 | Price 8.00 | Shares 125,000
Buy 14 Aug 2024
Value US$3,000,000.00 | Price 8.00 | Shares 375,000
Sale 14 Aug 2024
Value US$20,916.00 | Price 9.00 | Shares 2,324
Sale 14 Aug 2024
Value US$156,249.00 | Price 9.00 | Shares 17,361
Sale 14 Aug 2024
Value US$47,826.00 | Price 9.00 | Shares 5,314
Buy 14 Aug 2024
Value US$1,000,000.00 | Price 8.00 | Shares 125,000
Buy 14 Aug 2024
Value US$3,000,000.00 | Price 8.00 | Shares 375,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-07 2026-01-05 S Sale
3.3
THOMSON TODD S
Non-Executive Director Large shareholder
8,411 -4.3%
265.44
US$4,542,047 		8,411 -4.3% 265.44 US$4,542,047
2025-12-11 2025-12-11 PrS Proposed sale
Kairos Venture Partners II, L.P.

Affiliate
81,000
403.23
US$3,156,843 		81,000 403.23 US$3,156,843
2025-06-30 2025-06-27 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
19,718 -42.8%
194.20
US$4,107,647 		19,718 -42.8% 194.20 US$4,107,647
2025-06-30 2025-06-27 B Purchase
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
71,428 +57.1%
7.00
US$499,996 		71,428 +57.1% 7.00 US$499,996
2025-06-30 2025-06-27 B Purchase
2.9
Kreis Leslie W.
Non-Executive Director Large shareholder
71,428 +57.1%
7.00
US$499,996 		71,428 +57.1% 7.00 US$499,996
2024-08-16 2024-08-14 S Sale
3.3
THOMSON TODD S
Non-Executive Director
18,750 -1.6%
8.00
US$150,000 		18,750 -1.6% 8.00 US$150,000
2024-08-14 2024-08-14 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
2,324 -1.7%
9.00
US$20,916 		2,324 -1.7% 9.00 US$20,916
2024-08-14 2024-08-14 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
17,361 -1.7%
9.00
US$156,249 		17,361 -1.7% 9.00 US$156,249
2024-08-14 2024-08-14 S Sale
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
5,314 -1.7%
9.00
US$47,826 		5,314 -1.7% 9.00 US$47,826
2024-08-14 2024-08-14 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
125,000 +inf%
8.00
US$1,000,000 		125,000 +inf% 8.00 US$1,000,000
2024-08-14 2024-08-14 B Purchase
2.7
Fletcher Aaron G.L.
Non-Executive Director Large shareholder
375,000 +42.4%
8.00
US$3,000,000 		375,000 +42.4% 8.00 US$3,000,000
2024-08-14 2024-08-14 S Sale
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
2,324 -1.7%
9.00
US$20,916 		2,324 -1.7% 9.00 US$20,916
2024-08-14 2024-08-14 S Sale
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
17,361 -1.7%
9.00
US$156,249 		17,361 -1.7% 9.00 US$156,249
2024-08-14 2024-08-14 S Sale
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
5,314 -1.7%
9.00
US$47,826 		5,314 -1.7% 9.00 US$47,826
2024-08-14 2024-08-14 B Purchase
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
125,000 +inf%
8.00
US$1,000,000 		125,000 +inf% 8.00 US$1,000,000
2024-08-14 2024-08-14 B Purchase
2.4
Bios Equity COF, LP
Non-Executive Director Large shareholder
375,000 +42.4%
8.00
US$3,000,000 		375,000 +42.4% 8.00 US$3,000,000
2024-08-14 2024-08-14 S Sale
2.9
Kreis Leslie W.
Large shareholder
2,324 -1.7%
9.00
US$20,916 		2,324 -1.7% 9.00 US$20,916
2024-08-14 2024-08-14 S Sale
2.9
Kreis Leslie W.
Large shareholder
17,361 -1.7%
9.00
US$156,249 		17,361 -1.7% 9.00 US$156,249
2024-08-14 2024-08-14 S Sale
2.9
Kreis Leslie W.
Large shareholder
5,314 -1.7%
9.00
US$47,826 		5,314 -1.7% 9.00 US$47,826
2024-08-14 2024-08-14 B Purchase
2.9
Kreis Leslie W.
Large shareholder
125,000 +inf%
8.00
US$1,000,000 		125,000 +inf% 8.00 US$1,000,000
2024-08-14 2024-08-14 B Purchase
2.9
Kreis Leslie W.
Large shareholder
375,000 +42.4%
8.00
US$3,000,000 		375,000 +42.4% 8.00 US$3,000,000
Explore more

More insider trading research around Actuate Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America